The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the IRIS Business Services IPO is up to ₹15.18 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of IRIS Business Services IPO is ₹32.00 per share.
Beta Drugs IPO opens on Sep 29, 2017, while IRIS Business Services IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and IRIS Business Services IPO is Oct 04, 2017, and Oct 04, 2017, respectively.
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in IRIS Business Services IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in IRIS Business Services IPO.